Inactive blood marker SDMA emerges as potential predictor of cardiovascular risk in CKD
When University of Texas at Arlington researcher Paul J. Fadel and his colleagues launched a study on vascular health in…
Lubiprostone shows promise in slowing kidney disease progression
Chronic kidney disease (CKD) is a major health issue worldwide. Many patients end up requiring regular dialysis to…